Table 1.
Model | Parameter Estimates a | LnL | 2ΔlnL (p-Value) | Positively Selected Sites b,c |
---|---|---|---|---|
TET1 | ||||
M0 | ω = 0.385 | −87,143.158462 | None | |
M1a | ω0 = 0.205, p0 = 0.623, ω1 = 1.000, p1 = 0.377 |
−86,007.766228 | Not allowed | |
M2a | ω0 = 0.205, p0 = 0.623, ω1 = 1.000, p1 = 0.298, ω2 = 1.000, p2 = 0.078 |
−86,007.766228 | M2a vs. M1a | None |
0 (p = 1) | ||||
M7 | p = 0.679, q = 0.983 | −85,718.609725 | Not allowed | |
M8 |
p0 = 0.962, p = 0.744, q = 1.197, p1 = 0.038, ω1 = 1.294 |
−85,707.99818 | M8 vs. M7 | 524F, 811M |
21.22309 (p < 0.001) | ||||
TET2 | ||||
M0 | ω = 0.346 | −75,677.716183 | None | |
M1a | ω0 = 0.184, p0 = 0.664, ω1 = 1.000, p1 = 0.336 |
−74,593.700860 | Not allowed | |
M2a | ω0 = 0.184, p0 = 0.664, ω1 = 1.000, p1 = 0.292, ω2 = 1.000, p2 = 0.044 |
−74,593.700860 | M2a vs. M1a | None |
0 (p = 1) | ||||
M7 | p = 0.617, q = 1.064 | −74,286.497185 | Not allowed | |
M8 |
p0 = 0.978, p = 0.671, q = 1.250, p1 = 0.022, ω1 = 1.558 |
−74,265.863135 | M8 vs. M7 | 123R*, 469V, 673V, 968P, 1002T, 1205S, 1767S |
41.2681 (p < 0.001) | ||||
TET3 | ||||
M0 | ω = 0.115 | −48,719.653509 | None | |
M1a | ω0 = 0.056, p0 = 0.860, ω1 = 1.000, p1 = 0.140 |
−47,597.069946 | Not allowed | |
M2a | ω0 = 0.056, p0 = 0.859, ω1 = 1.000, p1 = 0.139, ω2 = 999.000, p2 = 0.002 |
−47,599.818203 | M2a vs. M1a | None |
−5.496514 (p = 1) | ||||
M7 | p = 0.237, q = 1.380 | −47,268.934744 | Not allowed | |
M8 |
p0 = 0.999, p = 0.237, q = 1.380, p1 = 0.001, ω1 = 999.000 |
−47,270.552239 | M8 vs. M7 | None |
−3.23499 (p = 1) |
a p and q denote the parameters of the β distribution, β (p, q), which determine that of ω values; b Amino acid sites inferred to be under positive selection are shown with a posterior probability PP > 0.95; * Posterior probability (PP) > 0.99; c The referenced sequences for the TET1, TET2 and TET3 genes were human TET1, human TET2, and human TET3, respectively.